Related Experiment Video
Updated: Mar 30, 2026
Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
Treatment of Aggressive Pelvic Fibromatosis With Interferon
Femke Ariën1, Jacomijntje M Aleman, Bart Op de Beeck
1Multidisciplinary Breast Clinic, Gynecological Oncology Unit, Department of Obstetrics and Gynecology, and the Department of Radiology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.
Background:
Fibromatosis is a rare, noninvasive but aggressive tumor. The tumor displaces tissue by "pushing" the normal structures aside. Optimal treatment should be individualized.
Case:
A 35-year-old woman presented with a recurrent fibromatosis, which filled the vagina and extended into the pelvis. The classical surgical removal would have had a high morbidity. Therefore, it was decided, after shared decision-making, to opt for treatment with interferon. The side effects of the therapy were tolerable, and a complete regression of the fibromatosis was achieved. At present, 13 years after the diagnosis and 7 years after discontinuation of the therapy, the patient is well with no signs of disease.
Conclusion:
Interferon may be considered as primary treatment for extensive pelvic fibromatosis.
